BeOne Medicines Ltd. (ONC) Cash Flow Statement
BeOne Medicines Ltd. (ONC) generated $1.5B of operating cash flow over the twelve months to 2026-06-30, spent $153.9M on capital expenditure and had free cash flow of $1.3B, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
ONCBeOne Medicines Ltd.Follow ONC — free
—
Price chart with a free account
- Market cap
- 42.9B
- P/E TTM
- 67.6
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 5 Nov, in 11 days
| Line | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -0.09 | 0.01 | -0.55 | -0.75 | -1.28 | -1.30 | -1.50 | -1.16 | -0.14 | 1.13 | 1.48 | |
| Capital expenditure | 0.02 | 0.05 | 0.07 | 0.09 | 0.12 | 0.26 | 0.33 | 0.56 | 0.49 | 0.19 | -0.15 | |
| Free cash flow | -0.11 | -0.03 | -0.62 | -0.84 | -1.40 | -1.56 | -1.82 | -1.72 | -0.63 | 0.94 | 1.33 | |
| Stock-based compensation | 0.01 | 0.04 | 0.09 | 0.13 | 0.18 | 0.24 | 0.30 | 0.37 | 0.44 | 0.51 | — |
USD billions · SEC XBRL
BeOne Medicines Ltd. — questions
- What is BeOne Medicines Ltd.'s operating cash flow?
- $1.5B over the twelve months to 2026-06-30.
- How much does BeOne Medicines Ltd. spend on capital expenditure?
- $153.9M over the twelve months to 2026-06-30.
- What is BeOne Medicines Ltd.'s free cash flow?
- $1.3B over the twelve months to 2026-06-30: operating cash flow minus capital expenditure.
Every figure on this page comes from BeOne Medicines Ltd.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.